Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 3No longer available 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Arthritis, Psoriatic 2Adenomatous Polyposis Coli 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × guselkumab × Clear all
NCT03649971 2025-02-03

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

Janssen Research & Development, LLC

Phase 1 Completed
77 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

NCT03796858 2025-02-03

COSMOS

Janssen Pharmaceutica N.V., Belgium

Phase 3 Completed
285 enrolled

Arthritis, Psoriatic

NCT03162796 2021-02-03

Discover-1

Janssen Research & Development, LLC

Phase 3 Completed
383 enrolled 106 charts

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡